LeonaBio (LONA) Other Operating Expenses (2023 - 2026)

LeonaBio (LONA) has 4 years of Other Operating Expenses data on file, last reported at -$17.2 million in Q1 2026.

• Quarterly Other Operating Expenses fell 125.31% year-over-year to -$17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.9 million (down 6.15% YoY) and the FY2025 annual result came in at $68.1 million, changed N/A from the prior year.
• Other Operating Expenses fell to -$17.2 million in Q1 2026 per LONA's latest filing, from $86.4 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $86.4 million in Q4 2025 and bottomed at -$24.8 million in Q1 2024.
• The 4-year median for Other Operating Expenses is -$5.2 million (2025), against an average of $15.6 million.
• The widest annual swing landed in 2024, when Other Operating Expenses jumped 4636.81%; it then plunged 125.31% in 2026.
• Tracing LONA's Other Operating Expenses over 4 years: stood at $1.6 million in 2023, then jumped by 4636.81% to $75.8 million in 2024, then increased by 14.02% to $86.4 million in 2025, then tumbled by 119.96% to -$17.2 million in 2026.
• Per Business Quant, the three latest LONA Other Operating Expenses figures stand at -$17.2 million (Q1 2026), $86.4 million (Q4 2025), and -$5.2 million (Q3 2025).

Peer Comparison